Syntal Capital Partners’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-46,286
Closed -$977K 99
2019
Q4
$977K Buy
46,286
+23,972
+107% +$485K 0.55% 49
2019
Q3
$436K Sell
22,314
-7,361
-25% -$135K 0.11% 147
2019
Q2
$517K Sell
29,675
-3,315
-10% -$59.7K 0.11% 158
2019
Q1
$610K Buy
+32,990
New +$588K 0.28% 61

Other funds holding MPT

Syntal Capital Partners's MPT Position: Q1 2020 in Review

Syntal Capital Partners sold out of Medical Properties Trust (MPT) in Q1 2020, closing a stake of 46,286 shares — an estimated $977K sold.

Syntal Capital Partners first reported a position in MPT in Q1 2019 and held it in 4 quarters. The position peaked at $977K in Q4 2019. 495 funds tracked by Wall St. Rank hold MPT as of Q1 2020.

  • Syntal Capital Partners reported no remaining Medical Properties Trust position as of Q1 2020 after selling out during the quarter.
  • Syntal Capital Partners sold 46,286 Medical Properties Trust shares in Q1 2020, an estimated $977K.
  • Syntal Capital Partners first reported a position in Medical Properties Trust in Q1 2019 and held it in 4 quarters.
  • Syntal Capital Partners's Medical Properties Trust position peaked at $977K in Q4 2019.
  • 495 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2020.

Based on Syntal Capital Partners's 13F filing for Q1 2020, filed 7 May 2020.